Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Abcellera Biologics Inc stock

Learn how to easily invest in Abcellera Biologics Inc stock.

AbCellera Biologics Inc. completed its initial public offering and its shares are now available on the Nasdaq under "ABCL." Vancouver-based AbCellera is an AI-powered drug discovery company working with Eli Lilly & Co. on a COVID-19 vaccine.

How to buy Abcellera Biologics Inc stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – ABCL. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for options trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Abcellera Biologics Inc stock price (NASDAQ: ABCL)

Use our graph to track the performance of ABCL stocks over time.

Abcellera Biologics Inc shares at a glance

Information last updated 2023-03-30.
Latest market close$7.54
52-week range$5.42 - $14.97
50-day moving average $9.01
200-day moving average $10.53
Wall St. target price$28.33
PE ratio 14.85
Dividend yield $0 (0%)
Earnings per share (TTM) $0.50

Buy Abcellera Biologics Inc stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs, Treasury Bills
Get $50 - $700
when you open and fund an account with $10,000 - $250,000+
Stocks, Bonds, Options, Mutual funds, ETFs, Futures
Get up to $600 or more
when you open and fund a new account.
E*TRADE offers commission-free stocks, access to mutual funds and advanced trading tools. Other fees apply.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Abcellera Biologics Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Abcellera Biologics Inc price performance over time

Historical closes compared with the close of $7.54 from 2023-03-31

1 week (2023-03-22) 3.15%
1 month (2023-02-28) -10.24%
3 months (2022-12-29) -24.98%
6 months (2022-09-29) -23.45%
1 year (2022-04-01) -25.57%
2 years (2021-04-01) -75.45%
3 years (2020-03-28) N/A
5 years (2018-03-28) N/A

Is Abcellera Biologics Inc stock undervalued or overvalued?

Valuing Abcellera Biologics Inc stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Abcellera Biologics Inc's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

To put Abcellera Biologics Inc's EBITDA into context you can compare it against that of similar companies.

Abcellera Biologics Inc financials

Revenue TTM $485.4 million
Operating margin TTM 44.6%
Gross profit TTM $311.1 million
Return on assets TTM 9.47%
Return on equity TTM 14.03%
Profit margin 32.66%
Book value $4.30
Market capitalisation $2.2 billion

TTM: trailing 12 months

Abcellera Biologics Inc share dividends

We're not expecting Abcellera Biologics Inc to pay a dividend over the next 12 months.

Abcellera Biologics Inc share price volatility

Over the last 12 months, Abcellera Biologics Inc's shares have ranged in value from as little as $5.42 up to $14.97. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Abcellera Biologics Inc's is -0.0916. This would suggest that Abcellera Biologics Inc's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Abcellera Biologics Inc has bucked the trend.

To put Abcellera Biologics Inc's beta into context you can compare it against those of similar companies.

Abcellera Biologics Inc overview

AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. It has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada. .

Frequently asked questions

What percentage of Abcellera Biologics Inc is owned by insiders or institutions?
Currently 28.641% of Abcellera Biologics Inc shares are held by insiders and 46.461% by institutions.
How many people work for Abcellera Biologics Inc?
Latest data suggests 495 work at Abcellera Biologics Inc.
When does the fiscal year end for Abcellera Biologics Inc?
Abcellera Biologics Inc's fiscal year ends in December.
Where is Abcellera Biologics Inc based?
Abcellera Biologics Inc's address is: 2215 Yukon Street, Vancouver, BC, Canada, V5Y 0A1
What is Abcellera Biologics Inc's ISIN number?
Abcellera Biologics Inc's international securities identification number is: CA00288U1066

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site